← Leaderboards
Robin Elizabeth Bachelder
Beth Israel Deaconess Medical Center
$1,780,554
Attributed
$1,780,554
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $204.9K · FY2005–25$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,780,554 · 5
By mechanism
K01$736,178 · 1
U54$627,817 · 2
R21$375,623 · 1
F32$40,936 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Harold Fisher Dvorak$13,877,917
- Zhao-Yi Wang$2,879,953
- David McDermott$9,360,637
- Karl S Matlin$2,623,721
- Laura E Benjamin$10,185,711
Others in their field
Top investigators on “Area”
- David Heimbrook · Leidos Biomedical Research, Inc.$781,609,239
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
AreaMalignant NeoplasmsNeoplastic ProcessAthymic MousePhosphatidylinositol 3 KinaseNeoplasm /Cancer Blood SupplyNeoplasm /Cancer InvasivenessNerve /Myelin ProteinBlocking AntibodyEngineeringEventEducational WorkshopGraduate StudentBioinformatics ToolLeadershipFamilyFacultyFestivalCancer PatientCommunitiesClinical TranslationChildCancer CellCarcinoma
Grant awards (13)
Outreach Core$159,750
U54 · FY2025 · CA · contact PI
Outreach Core$151,762
U54 · FY2024 · CA · contact PI
Outreach Core$156,555
U54 · FY2023 · CA · contact PI
Outreach Core$159,750
U54 · FY2022 · CA · contact PI
Nuclear Snail-1 in the progression of Estrogen Receptor(-) invasive breast cancer$170,738
R21 · FY2012 · CA · contact PI
Nuclear Snail-1 in the progression of Estrogen Receptor(-) invasive breast cancer$204,885
R21 · FY2011 · CA · contact PI
Novel function for VEGF in breast carcinoma survival$150,062
K01 · FY2006 · CA · contact PI
Novel function for VEGF in breast carcinoma survival$129,600
K01 · FY2005 · CA
Novel function for VEGF in breast carcinoma survival$22,329
K01 · FY2005 · CA
Novel function for VEGF in breast carcinoma survival$151,929
K01 · FY2004 · CA
Novel function for VEGF in breast carcinoma survival$151,929
K01 · FY2003 · CA
Novel function for VEGF in breast carcinoma survival$130,329
K01 · FY2002 · CA
ALPHA6 BETA4 INTEGRIN REGULATION OF CARCINOMA SURVIVAL$40,936
F32 · FY2000 · CA